Post-translational Modification Enrichment and Quantitation for Precision Medicine and Drug Development

Featured Speakers: Connie R. Jimenez, PhD and Manuel Tzouros, PhD

Innovative mass spectrometry-based proteomics is a powerful tool for obtaining insights into disease-related cellular signaling pathways, biomarkers, and potential drug targets. This technology is being used to investigate phosphorylation of extracellular and intracellular proteins with the aim of improving early diagnosis and treatment of cancer and neurodegenerative diseases. In addition to phosphorylation studies, this technology can also be used to detect other PTMs including ubiquitylation. This on-demand webinar considers study design for label-free analysis, enrichment strategies, and data analysis involving both preclinical models and clinical samples with a focus on cancer.